Does BIMEKIZUMAB Cause Oral candidiasis? 146 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 146 reports of Oral candidiasis have been filed in association with BIMEKIZUMAB (Bimzelx). This represents 5.9% of all adverse event reports for BIMEKIZUMAB.
146
Reports of Oral candidiasis with BIMEKIZUMAB
5.9%
of all BIMEKIZUMAB reports
0
Deaths
18
Hospitalizations
How Dangerous Is Oral candidiasis From BIMEKIZUMAB?
Of the 146 reports, 18 (12.3%) required hospitalization, and 2 (1.4%) were considered life-threatening.
Is Oral candidiasis Listed in the Official Label?
Yes, Oral candidiasis is listed as a known adverse reaction in the official FDA drug label for BIMEKIZUMAB.
What Other Side Effects Does BIMEKIZUMAB Cause?
Psoriatic arthropathy (615)
Psoriasis (400)
Drug ineffective (293)
Inappropriate schedule of product administration (238)
Injection site pain (225)
Product dose omission issue (163)
Off label use (160)
Fatigue (138)
Therapy interrupted (138)
Pneumonia (118)
What Other Drugs Cause Oral candidiasis?
PREDNISONE (581)
ADALIMUMAB (548)
SECUKINUMAB (520)
METHOTREXATE (464)
FLUTICASONE\SALMETEROL (402)
INFLIXIMAB (345)
METRONIDAZOLE (327)
SULFAMETHOXAZOLE\TRIMETHOPRIM (323)
METHYLPREDNISOLONE (322)
ACETAMINOPHEN (294)
Which BIMEKIZUMAB Alternatives Have Lower Oral candidiasis Risk?
BIMEKIZUMAB vs BIMEKIZUMAB-BKZX
BIMEKIZUMAB vs BINIMETINIB
BIMEKIZUMAB vs BIOFLAVONOIDS
BIMEKIZUMAB vs BIOTIN
BIMEKIZUMAB vs BIPERIDEN